In vitro and in vivo characterization of the JAK1 selectivity of upadacitinib (ABT-494)
Anti-cytokine therapies such as adalimumab, tocilizumab, and the small molecule JAK inhibitor tofacitinib have proven that cytokines and their subsequent downstream signaling processes are important in the pat...